SCHEMBL4885449

SCHEMBL4885449

CC(C)(C)[Si](C)(C)O[C@@H]1CCN(c2ccc(-n3ccc(OCc4ccccc4)cc3=O)c(=O)[nH]2)C1

nearest known ligand 0.48

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 16/20 0.48
KCNH2 Q12809 4/20 0.42
DPP4 P27487 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4888767 0.84 GPR119 (0.30)
SCHEMBL4886169 0.84 MCHR1 (0.64) MCHR1KCNH2DPP4
SCHEMBL4888022 0.82 MCHR1 (0.52) MCHR1KCNH2DPP4
SCHEMBL4795050 0.82 MCHR1 (0.52) MCHR1KCNH2DPP4
SCHEMBL1779304 0.82 MCHR1 (0.50) MCHR1KCNH2
SCHEMBL4885441 0.81 MCHR1 (0.71) MCHR1KCNH2DPP4
Hydrochloric Acid SCHEMBL4728285 0.81 MCHR1 (0.49) MCHR1KCNH2DPP4
Hydrochloric Acid SCHEMBL4728290 0.81 MCHR1 (0.49) MCHR1KCNH2DPP4
SCHEMBL4887387 0.81
SCHEMBL4796931 0.80 MCHR1 (0.49) MCHR1KCNH2DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008041090-A1 MALANIN CONCENTRATING HORMONE RECEPTOR-1 ANTAGONIST PYRIDINONES PFIZER LIMITED (GB) 2008-04-10 WO disclosed
US-20080085884-A1 Melanin Concentrating Hormone Receptor-1 Antagonist Pyridinones PFIZER INC 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085884-A1 Melanin Concentrating Hormone Receptor-1 Antagonist Pyridinones MCHR1, MCHR2, MC1R MCHR1 1/4885KCNH2 3042/4885DPP4 2273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.